Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers

Cell

Volumn 90, Issue 4, 1997, Pages 809-819

  Kaghad, Mourad ^a   Bonnet, Helene ^a   Yang, Annie ^b   Creancier, Laurent ^a   Biscan, Jean Christophe ^a   Valent, Alexandre ^c   Minty, Adrian ^a   Chalon, Pascale ^a   Lelias, Jean Michel ^a   Dumont, Xavier ^a   Ferrara, Pascual ^a   McKeon, Frank ^b   Caput, Daniel ^a  

^a SANOFI   (France)

^b HARVARD MEDICAL SCHOOL   (United States)

^c INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ALLELISM; ARTICLE; CANCER GENETICS; CELL CYCLE; CHROMOSOME 1P; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; NEUROBLASTOMA; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0030812331     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)80540-1     Document Type: Article

References (59)

1. Ambros, P.F., Ambros, I.M., Strehl, S., Bauer, S., Luegmayr, A., Kovar, H., Ladenstein, R., Fink, F.-M., Horcher, E., Printz, G., et al. (1995). Regression and progression in neuroblastoma. Does genetics predict tumour behaviour? Eur. J. Cancer 31A, 510-515.
2. Amler, L.C., Corvi, R., Praml, C., Savelyeva, L., Le Paslier, D., and Schwab, M. (1995). Reciprocal translocation at 1p36.2/D1S160 in a neuroblastoma cell line: isolation of a YAC clone at the break. Eur. J. Cancer 31A, 527-530.
3. Baker, S.J., Markowitz, S., Fearon, E.R., Willson, J.K., and Vogelstein, B. (1990). Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249, 912-915.
4. Balaban, G.B., Herlyn, M., Clark, W.H., Jr., and Nowell, P.C. (1986). Karyotypic evolution in human malignant melanoma. Can. Genet. Cytogenet. 19, 113-122.
5. Ballester, R., Marchuk, D., Boguski, M., Saulino, A., Letcher, R., Wigeler, M., and Collins, F. (1990). The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell 63, 851-859.
6. Barlow, D.P. (1995). Gametic imprinting in mammals. Science 270, 1610-1613.
7. Benedict, W.F., Murphree, A.L., Banerjee, A., Spina, C.A., Sparkes, M.C., and Sparkes, R.S. (1983). Patient with 13 chromosome deletion: evidence that the retinoblastoma gene is a recessive cancer gene. Science 279, 973-975.
8. Bernards, R. (1995). Flipping the Myc switch. Curr. Biol. 5, 859-861.
9. Biegel, J.A., White, P.S., Marshall, H.N., Fujimori, M., Zackai, E.H., Scher, C.D., and Brodeur, G.M. (1993). Constitutional 1p36 deletion in a child with neuroblastoma. Am. J. Hum. Genet. 52, 176-182.
10. Brodeur, G.M., Sekhon, G., and Goldstein, M.N. (1977). Chromosomal aberrations in human neuroblastomas. Cancer 40, 2256-2263.
11. Brodeur, G.M., Seeger, R.C., Schwab, M., Varmus, H.E., and Bishop, J.M. (1984). Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224, 1121-1124.
12. Buchberg, A.M., Cleveland, L.S., Jenkins, N.A., and Copeland, N.G. (1990). Sequence homology shared by neurofibromatosis type-1 gene and IRA-1 and IRA-2 negative regulators of the RAS cyclic AMP pathway. Nature 347, 291-294.
13. Caelles, C., Helmberg, A., and Karin, M. (1994). p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature 370, 220-223.
14. Caron, H., Peter, M., van Sluis, P., Speleman, F., de Kraker, J., Laureys, G., Michon, J., Brugieres, L., Voute, P.A., Westerveld, A., et al. (1995). Evidence for two tumour suppressor loci on chromosomal bands 1p35-36 involved in neuroblastoma: one probably imprinted, another associated with N-myc amplification. Hum. Mol. Genet. 4, 535-539.
15. Cavenee, W.K., Dryja, T.P., Phillips, R.A., Benedict, W.F., Godbut, R., Gallie, B.L., Murphee, A.L., Strong, L.C., and White, R.L. (1983). Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 305, 779-784.
16. Cheng, N.C., Van Roy, N., Chan, A., Beitsma, M., Westerveld, A., Speleman, F., and Versteeg, R. (1995). Deletion mapping in neuroblastoma cell lines suggests two distinct tumor suppressor genes in the 1p35-36 region, only one of which is associated with N-myc amplification. Oncogene 10, 291-297.
17. Cheng, N.C., Chan, A.J.K., Beitsma, M.M., Speleman, F., Westerveld, A., and Versteeg, R.A. (1996). Human modifier of methylation for class I Hlagenes (memo-1) maps to chromosomal bands 1p35-36.1. Hum. Mol. Genet. 5, 309-317.
18. Davidoff, A.M., Pence, J.C., Shorter, N.A., Iglehart, J.D., and Marks, J.R. (1992). Expression of p53in human neuroblastoma-and neuroepithelioma-derived cell lines. Oncogene 7, 127-133.
19. Donehower, L.A., Harvey, M., Slagle, B.L., McArthur, M.J., Montgomery, C.A., Jr., Butel, J.S., and Bradley, A. (1992). Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356, 215-221.
20. Dracopoli, N.C., Harnett, P., Bale, S.J., Stanger, B.Z., Tucker, M.A., Housman, D.E., and Kefford, R.F. (1989). Loss of alleles from the distal short arm of chromosome 1 occurs late in melanoma tumor progression. Proc. Natl. Acad. Sci. USA 56, 4614-4618.
21. EI-Deiry, W.S., Tokino, T., Velculescu, V.E., Levy, D.B., Parsons, R., Trent, J.M., Lin, D., Mercer, W.E., Kinzler, K.W., and Vogelstein, B. (1993). WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825.
22. Fearon, E.R., Hamilton, S.R., and Vogelstein, B. (1987). Clonal analysis of human colorectal tumors. Science 238, 193-197.
23. Genuardi, M., Tsihira, H., Anderson, D.E., and Saunders. G.F. (1989). Distal deletion of chromosome Ip in ductal carcinoma of the breast. Am. J. Hum. Genet. 45, 73-82.
24. Graeber, T.G., Osmanian, C., Jacks, T., Housman, D.E., Koch, C.J., Lowe, S.W., and Giaccia, A.J. (1996). Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379, 88-91.
25. Gyuris, J., Golemis, E., Chertov, H., and Brent, R. (1993). Cdi1, a human G1 and S phase protein phosphatase that associates with Cdk2. Cell 75, 791-803.
26. Hartwell, L.H., and Kastan, M.B. (1994). Cell cycle control and cancer. Science 266, 1821-1828.
27. Heald, R., McLoughlin, M., and McKeon, F. (1993). Human Wee1 maintains mitotic timing by protecting the nucleus from cytoplasmically activated cdc2 kinase. Cell 74, 463-474.
28. Holland, P.W.H. (1996). Hox genes and chordate evolution. Dev. Biol. 173, 382-395.
29. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C.C. (1991). p53 mutations in human cancers. Science 253, 49-53.
30. Huttner, W.B., and Brand, M. (1997). Asymmetric division and polarity of neuroepithelial cells. Curr. Opin. Neurobiol. 7, 29-39.
31. Jacks, T., Remington, L., Williams, B.O., Schmitt, E.M., Halachmi, S., Bronson, R.T., and Weinberg, R.A. (1994). Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4, 1-7.
32. Kastan, M.B., Zhan, Q., EI-Deiry, W.S., Carrier, F., Jacks, T., Walsh, W.V., Plunkett, B.S., Vogelstein, B., and Fornace, A.J., Jr. (1992). A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71, 587-597.
33. Kessis, T.D., Slebos, R.J., Nelson, W.G., Kastan, M.B., Plunkett, B.S., Han, S.M., Lorincz, AT., Hedrick, L., and Cho, K.R. (1993). Human papilloma virus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. Proc. Natl. Acad. Sci. USA 90, 3988-3992.
34. Kinzler, K.W., and Vogelstein, B. (1996). Life (and death) in a malignant tumour. Nature 379, 19-20.
35. Knudson, A.G., Jr., and Meadows, AT. (1980). Regression of neuroblastoma IV-S: a genetic hypothesis. New Eng. J. Med. 302, 1254-1256.
36. Ko, L.J., and Prives, C. (1996). p53: puzzle and paradigm. Genes Dev. 10, 1054-1072.
37. Lane, D.P., and Crawford, L.V. (1979). T antigen is bound at a host protein in SV 40-transformed cells. Nature 278, 261-263.
38. Laureys, G., Versteeg, R., Speleman, F., van der Drift, P., Francke, U., Opdenakker, G., and Van Roy, N. (1995). Characterisation of the chromosome breakpoints in a patient with a constitutional translocation t(1;17)(p36.31;q11.2-q12) and neuroblastoma. Eur. J. Cancer 31 A, 523-526.
39. Levine, A.J., Wu, M.C., Chang, A., Silver, A., Attiyeh, E.F., Lin, J., and Epstein, C.B. (1995). The spectrum of mutations at the p53 locus. Evidence for tissue-specific mutagenesis, selection of mutant alleles, and a "gain of function" phenotype. Ann. NY Acad. Sci. 768, 111-128.
40. Li, F.P., and Fraumeni, J.F., Jr. (1969). Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann. Intern. Med. 71, 747-752.
41. Lin, J., Chen, J., Elenbaas, B., and Levine, A.J. (1994a). Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B-kD protein. Genes Dev. 8, 1235-1246.
42. Lin, J., Wu, X., Chen, J., Chang, A., and Levine, A.J. (1994b). Functions of the p53 protein in growth regulation and tumor suppression. CSH Sym. Quant. Biol. 59, 215-223.
43. Linzer, D.I., and Levine, A.J. (1979). Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell 17, 43-52.
44. Livingstone, L.R., White, A., Sprouse, J., Livanos, E., Jacks, T., and Tisty, T.D. (1992). Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70, 923-935.
45. Lowe, S.W., Schmitt, E.M., Smith, S.W., Osborne, B.A., and Jacks, T. (1993). p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362, 847-849.
46. Malkin, D., Li, F.P., Strong, L.C., Fraumeni, J.F., Jr., Nelson, C.E., Kim, D.H., Kassel, J., Gryka, M.A., Bischoff, F.Z., Tainsky, M.A., et al. (1990). Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250, 1233-1238.
47. Maniatis, T., Fritsch, E.F., and Sam brook, J. (1992). Molecular Cloning: A Laboratory Manual (Cold Spring Harbor: Cold Spring Harbor Laboratory).
48. Moll, U.M., LaQuaglia, M., Benard, J., and Riou, G. (1995). Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors. Proc. Natl. Acad. Sci. USA 92, 4407-4411.
49. Nigro, J.M., Baker, S.J., Preisinger, A.C., Jessup, J.M., Hostetterm, R., Cleary, K., Bigner, S.H., Davidson, N., Baylin, S., Devilee, P., et al. (1989). Mutations in p53 gene occur in diverse human tumour types. Nature 342, 705-708.
50. Prats, H., Kaghad, M., Prats, A.C., Klagsbrun, M., Lelias, J.M., Liauzun, P., Chalon, P., Tauber, J.P., Amalric, F., Smith, J.A., and Caput, D. (1989). High molecular mass forms of basic fibroblast growth factor are initiated by alternative CUG codons. Proc. Natl. Acad. Sci. USA 86, 1836-1840.
51. Ross, R.A., Spengler, B.A., Domenech, C., Porubcin, M., Rettig, W.J., and Biedler, J.L. (1995). Human neuroblastoma 1-type cells are malignant neural crest stem cells. Cell Growth Differ. 6, 449-456.
52. Sozzi, G., Bertoglio, M.G., Pilotti, S., Rilke, F., Pierotti, M.A., and Delia Porta, G. (1988). Cytogenetic studies in primary and metastatic neuroendocrine Merkel cell carcinoma. Cancer Genet. Cytogenet. 30, 151-158.
53. Takeda, O., Homma, C., Maseki, N., Sakurai, M., Kanda, N., Schwab, M., Nakamura, Y., and Kaneko, Y. (1994). There may be two tumor suppressor genes on chromosome arm 1p closely associated with biologically distinct subtypes of neuroblastoma. Genes Chrom. Cancer 10, 30-39.
54. Versteeg, R., Caron, H., Cheng, N.C., van der Drift, P., Slater, R., Westerveld, A., Voute, P.A., Delattre, O., Laureys, G., Van Roy, N., et al. (1995). 1p36: every subband a suppressor? Eur. J. Cancer 31A, 538-541.
55. Weinberg, R. (1993). Tumor suppressor genes. Neuron 11, 191-196.
56. Werness, B.A., Levine, A.J., and Howley, P.M. (1990). Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248, 76-79.
57. White, P.S., Maris, J.M., Beltinger, C., Sulman, E., Marshall, H.N., Fujimori, M., Kaufman, B.A., Biegel, J.A., Allen, G., Hilliard, C., et al. (1995). A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3. Proc. Natl. Acad. Sci. USA 92, 5520-5524.
58. Yeh, S.H., Chen, P.J., Chen, H.L., Lai, M.Y., Wang, C.C., and Chen, D.S. (1994). Frequent genetic alterations at the distal region of chromosome 1p in human hepatocellular carcinomas. Cancer Res. 54, 4188-4192.
59. Zambetti, G.P., and Levine, A.J. (1993). A comparison of the biological activities of wild-type and mutant p53. FASEB J. 7, 855-865.